Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 17 clinical trials
Featured trial
A Randomized, Double-Blind, Double-Dummy, Active-Controlled Study Comparing the Efficacy, Safety and Tolerability of ABBV-951 to Oral Carbidopa/Levodopa in Advanced Parkinson's Disease Patients

The purpose of this study is to find out how well ABBV-951 works to control Parkinson's disease symptoms compared to oral Carbidopa (CD)/Levodopa (LD). The study is also

levodopa
carbidopa
  • 132 views
  • 23 Nov, 2020
  • 1 location
Featured trial
A Study to Evaluate the Safety and Efficacy of IPX203 in Parkinson's Disease Patients With Motor Fluctuations

To evaluate the safety and efficacy of IPX203 (carbidopa and levodopa) extended-release capsules (IPX203 ER CD-LD) in comparison to immediate release (IR) CD-LD in the

illicit drug
  • 139 views
  • 23 Nov, 2020
  • 1 location
Early ParkinSon wIth L-DOPA/DDCI and OpicapoNe (EPSILON Study)

/DDCI in adult patients with Parkinson's disease and end-of-dose motor fluctuations who cannot be stabilized on those combinations. Carbidopa and benserazide are both DDCIs used in association with L

  • 0 views
  • 04 Aug, 2021
  • 1 location
Enhancement of Stroke Rehabilitation With Levodopa (ESTREL)

Trial investigates the benefits and harms of Levodopa /Carbidopa 100/25mg compared to placebo (given in addition to standardized rehabilitation based on the principles of motor learning) and

  • 3 views
  • 27 Apr, 2022
  • 13 locations
CBD-Microglia PET Study

This study aims to examine the effect of cannabidiol (CBD) pre-treatment on brain microglial activation in healthy human subjects. Secondarily, this study aims to examine the effect of cannabidiol (CBD) pre-treatment on central pain-sensitization in healthy human subjects.

  • 0 views
  • 18 Sep, 2021
  • 1 location
A Study of the Efficacy and Safety of Carbidopa-Levodopa Extended-Release Tablets in Patients With Parkinson's Disease

It is a phase II randomized, parallel, double-blind, placebo-controlled, multi-center clinical trial of the efficacy and safety of WD-1603 Carbidopa-Levodopa Extended-Release Tablets in patients

levodopa
early parkinson's
carbidopa/levodopa
carbidopa
  • 0 views
  • 25 Jan, 2022
  • 1 location
Effects of Cannabidiol (CBD) on the Brain

Cannabidiol (CBD) is a phytocannabinoid that is one of 113 identified cannabinoids in the cannabis plant. It is derived from the hemp plant, and may treat conditions like pain, insomnia, and anxiety. CBD is a critical component of medical marijuana and does not cause the "high" typically associated with cannabis. …

  • 88 views
  • 01 Oct, 2021
  • 1 location
Cannabidiol, Morphine, Pain (CMP)

The purpose of the proposed study is to investigate the interaction of cannabidiol (CBD) and morphine effects on pain sensitivity. Cannabidiol is a cannabinoid (similar to cannabis, or marijuana) present in marijuana that alters some of the effects of marijuana.

morphine
opioid
oral morphine
  • 666 views
  • 13 Feb, 2022
  • 1 location
Novel Non-opioid Post-surgical Pain Treatment in Females

This study aims to determine if treatment with Carbidopa/Levodopa and Naproxen in females (biological sex) with acute pain after a bunionectomy or toe fusion (24hrs, 48hrs and 5 days) will

opioid
naproxen
bunionectomy
acute pain
  • 0 views
  • 27 Nov, 2021
  • 1 location
Methodology for Developing an Occlusal Appliance With CBD Active Carrier

Evaluation of the efficacy of the occlusal appliance with active cannabidiol (CBD) molecules in TMD patients

  • 0 views
  • 07 Mar, 2021
  • 1 location